EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Progress in Synthesis and Pharmacology of Telmisartan

Megha, Richa Srivastava iD, Ram Singh iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.71667 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Megha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Chemistry, Delhi Technological University, Delhi, India. Hauptthemen laut MEDLINE: Telmisartan, Benzimidazoles, Benzoates, Antihypertensive Agents. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Delhi Technological University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telmisartan is a benzimidazole derivative and a well‐known drug to treat hypertension. This is an angiotensin II receptor blocker (ARB) which helps to relax blood vessels. Studies have shown that telmisartan is effective in reducing cardiovascular disease, with a safety and efficacy profile. This review paper provides an overall understanding of telmisartan as an antihypertensive drug. The goal is to highlight the synthetic methodology of telmisartan, from its first synthesis in 1993. This review also discusses its two mechanisms of action: the Renin‐Angiotensin‐Aldosterone System (RAAS) inhibitor and partial agonist activity at the Peroxisome Proliferator‐activated receptor gamma (PPARγ) receptor. Effective repurposing of this drug for various diseases like chronic kidney illness, diabetes, fatty liver, and Alzheimer's has also been discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelmisartanBenzimidazolesBenzoatesAntihypertensive AgentsAngiotensin II Type 1 Receptor BlockersHumansPPAR gammaAnimalsRenin-Angiotensin SystemHypertension

Stichwörter der Autor:innen

Angiotensin receptor blockerRenin‐Angiotensin‐Aldosterone systemcardiovascular diseasesdiabeteshypertensionperoxisome proliferator‐activated receptor gammatelmisartan

Substanzen

TelmisartanBenzimidazolesPPAR gammaBenzoatesAntihypertensive AgentsAngiotensin II Type 1 Receptor Blockers

Autor:innen und Institutionen

  • Department of Applied Chemistry, Delhi Technological University, Delhi, India.

ORCID-Profile: Richa Srivastava, Ram Singh

Förderung

  • Delhi Technological University

Zitieren

APA

Megha, Srivastava, R., & Singh, R. (2026). Progress in Synthesis and Pharmacology of Telmisartan. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71667

Vancouver

Megha, Srivastava R, Singh R. Progress in Synthesis and Pharmacology of Telmisartan. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71667

BibTeX
@article{Megha2026,
  author = {Megha and Srivastava, Richa and Singh, Ram},
  title = {Progress in Synthesis and Pharmacology of Telmisartan},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.71667}
}
Kostenlos starten →